Pelikan

Pelikan Technologies was a medical device company focused on developing advanced blood glucose monitoring systems for patients with diabetes. The company's primary innovation was the Pelikan Sun, the world's first fully integrated electronic lancet and glucose measurement device, designed to make blood sampling less painful and more convenient. By automating the lancing process and integrating it with measurement, Pelikan aimed to improve patient compliance and disease management. The company was acquired by Sanofi-Aventis in 2008 to bolster Sanofi's diabetes care portfolio and integrate Pelikan's technology into their insulin delivery systems.